Skip to main content
OpenTrials

Clinical trial condition

ER+ Breast Cancer

Explore clinical trials studying ER+ Breast Cancer. Study availability and eligibility vary by location and protocol.

22 public trials 11 recruiting studies
Refine in advanced search Browse all conditions

ER+ Breast Cancer trial results

Recruiting

PAveMenT: Palbociclib and Avelumab in Metastatic AR+ Triple Negative Breast Cancer

NCT04360941

Conditions
Breast Diseases, Breast Neoplasms, ER+ Breast Cancer, +10 more
Locations
  • The Christie NHS Foundation Trust Manchester, Greater Manchester, United Kingdom
  • Addenbrooke's Hospital Cambridge University Hospitals NHS Foundation Trust Cambridge, United Kingdom
  • Beatson West of Scotland Cancer Centre Glasgow, United Kingdom
  • Hope Clinical Trials Cancer Centre Leicester, United Kingdom
View Trial Details
Recruiting

A Study on Adding Precisely Targeted Radiation Therapy (Stereotactic Body Radiation Therapy) to the Usual Treatment Approach (Drug Therapy) in People With Breast Cancer

NCT05534438

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +9 more
Locations
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Commack (Limited Protocol Activities) Commack, New York, United States
View Trial Details
Recruiting

Circulating Tumor DNA

NCT06923527

Conditions
ER+ Breast Cancer
Locations
  • Yale University New Haven, Connecticut, United States
  • Lombardi Comprehensive Cancer Center at Georgetown University Medical Center Washington D.C., District of Columbia, United States
  • Sidney Kimmel Comprehensive Cancer Center at John Hopkins Baltimore, Maryland, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Recruiting

A Study of the Impact of Endocrine Therapy on Surgical Outcomes in People With Lobular Breast Cancer

NCT07483307

Conditions
Adenocarcinoma, Breast Cancer, Breast Diseases, +14 more
Locations
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities) Commack, New York, United States
View Trial Details
Recruiting

A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies

NCT06395519

Conditions
Adnexal Diseases, Advanced or Metastatic Solid Tumors, BRCA Mutation, +52 more
Locations
  • Mayo Clinic Phoenix, Arizona, United States
  • Yale University, Yale Cancer Center New Haven, Connecticut, United States
  • Mayo Clinic Jacksonville, Florida, United States
  • University of Chicago Medical Center Chicago, Illinois, United States
View all 14 locations
View Trial Details
Recruiting

JAB-2485 Activity in Adult Patients With Advanced Solid Tumors

NCT05490472

Conditions
ARID1A Gene Mutation, Breast Diseases, Breast Neoplasms, +17 more
Locations
  • Henry Ford Health System Detroit, Michigan, United States
  • Washington University St Louis, Missouri, United States
  • Mary Crowley Cancer Research Dallas, Texas, United States
  • University of Utah Huntsman Cancer Institute Salt Lake City, Utah, United States
View Trial Details

Related conditions